UK halts trial of hydroxychloroquine in Covid-19 patients after no benefit found
June 05 2020 06:33 PM
Hydroxychloroquine drug is displayed by a pharmacist at the Rock Canyon Pharmacy in Provo, Utah, US
Hydroxychloroquine drug being displayed by a pharmacist at the Rock Canyon Pharmacy in Provo, Utah, US

Reuters/London

British scientists halted a large trial on Monday that had been exploring the use of the anti-malaria drug hydroxychloroquine in patients with the pandemic disease Covid-19 after initial results showed no evidence of benefit.
"We reviewed the data and concluded there is no evidence of a beneficial effect of hydroxychloroquine in patients hospitalised with Covid, and decided to stop enrolling patients to the hydroxychloroquine arm with immediate effect," said Martin Landray, an Oxford University professor who is co-leading the so-called RECOVERY trial.
"This is not a treatment (for Covid-19)," he added. 



There are no comments.

LEAVE A COMMENT Your email address will not be published. Required fields are marked*
MORE NEWS

HAPPENING IN DOHAMore